세계 펩타이드 합성 시장 규모는 2022년 6억 1,956만 달러로 예측 기간(2024-2031년) 동안 13.0%의 CAGR로 2023년 7억 11만 달러에서 2031년 18억 6,120만 달러로 성장할 것으로 예상됩니다.
세계 펩타이드 합성 시장은 펩타이드 기반 치료제에 대한 수요 증가로 인해 큰 성장을 이루고 있습니다. 다양한 생리적 기능과 대사과정을 조절하는 신호전달 분자로 작용하는 펩타이드는 기존 저분자 의약품이나 생물학적 제제에 비해 대사 안정성이 향상되고, 표적 특이성이 높으며, 결합 친화성이 강해 최근 주목받고 있습니다. 특히 암, 당뇨, HIV 등 만성질환 치료제로 전 세계적으로 80개 이상의 펩타이드 치료제가 승인되었으며, 그 치료 효과를 평가하기 위해 2015년 이후 630개 이상의 임상시험이 진행되고 있습니다. 특히 팬데믹 이후 펩타이드 기반 진단 및 치료제의 급증은 펩타이드 합성이 현대 의학의 필수 요소로서 펩타이드 합성에 대한 관심이 높아졌음을 반영합니다.
Global Peptide Synthesis Market size was valued at USD 619.56 million in 2022 and is poised to grow from USD 700.11 million in 2023 to USD 1861.20 million by 2031, growing at a CAGR of 13.0% during the forecast period (2024-2031).
The global peptide synthesis market has experienced significant growth driven by the increasing demand for peptide-based therapeutics. Peptides, which act as signaling molecules that regulate various physiological functions and metabolic processes, have gained traction in recent years due to their improved metabolic stability, target specificity, and stronger binding affinity compared to traditional small molecule drugs and biologics. Notably, over 80 peptide therapeutics have been approved globally for treating chronic conditions such as cancer, diabetes, and HIV, with more than 630 clinical trials conducted since 2015 to evaluate their therapeutic efficacy. The surge in peptide-based diagnostics and therapies, especially post-pandemic, reflects growing interest in peptide synthesis as an essential component of modern medicine.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Peptide Synthesis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Peptide Synthesis Market Segmental Analysis
Global Peptide Synthesis Market is segmented by Product & Services, Technology, end user and region. Based on Product & Services, the market is segmented into Reagents, Equipment, Services. Based on Technology, the market is segmented into Solid-Phase Peptide Synthesis, Solution-Phase Peptide Synthesis, Hybrid & Recombinant Technology. Based on end user, the market is segmented into Pharmaceutical & Biotechnology companies, CDMOs & CROs, Academic & Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Driver of the Global Peptide Synthesis Market
The growing demand for imaging technology to enable accurate diagnosis of chronic diseases is a significant driver for the global peptide synthesis market. Valued at over USD 30 billion in 2023, the peptide synthesis market is benefiting from the increasing use of peptide-based biosensors and biomarkers, both in invasive and non-invasive diagnostic applications. These advanced diagnostic tools are witnessing substantial demand, as they provide critical insights into various health conditions. The rise in healthcare applications for peptide-based biosensors, along with their ability to enhance disease detection and monitoring, is fueling market growth and creating new opportunities for peptide synthesis technologies. This trend is expected to continue driving market expansion in the coming years.
Restraints in the Global Peptide Synthesis Market
A significant restraint in the global peptide synthesis market is the reliance on contract manufacturing organizations (CMOs) for peptide production. Pharmaceutical companies are investing heavily in the development of peptide-based therapeutics, but the manufacturing process is mostly outsourced to CMOs, which are typically located in developed economies due to lower production costs. This reliance on external manufacturers can lead to challenges in maintaining strict adherence to standardization guidelines and safety standards, potentially affecting the consistency and quality of peptide products. Additionally, the limited control over the manufacturing process can introduce risks related to regulatory compliance, further constraining market growth.
Market Trends of the Global Peptide Synthesis Market
A key trend in the global peptide synthesis market is the steady rise in demand from the pharmaceutical industry, driven by increased research and development (R&D) investments. The pharmaceutical sector is witnessing significant growth, with R&D spending growing even faster. According to a 2020 survey by the US Census Bureau, pharmaceutical R&D expenditure has surged by over 25% over the past decade, reflecting a growing commitment to innovation. This trend is enhancing the funding available for the development of advanced peptide synthesis solutions and processes, further driving market growth. The surge in pharmaceutical R&D budgets is expected to continue fostering advancements in peptide synthesis technologies, expanding their applications and market opportunities.